Urethral cancer staging

Urethral cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Urethral cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT Scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Urethral cancer staging On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Urethral cancer staging All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Urethral cancer staging
CDC on Urethral cancer staging
Urethral cancer staging in the news
Blogs on Urethral cancer staging
Directions to Hospitals Treating Urethral cancer
Risk calculators and risk factors for Urethral cancer staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Staging

Stage Definitions by Depth of Invasion

Stage 0 (Tis, Ta): Limited to mucosa. Stage A (T1): Submucosal invasion. Stage B (T2): Infiltrating periurethral muscle or corpus spongiosum. Stage C (T3): Infiltration beyond periurethral tissue.

Female: Vagina, labia, muscle. Male: Corpus cavernosum, muscle.

Stage D1 (N+): Regional nodes; pelvic and inguinal. Stage D2 (N+, M+): Distant nodes; visceral metastases.==References==